Interaction of Mitochondrial Calcium and ROS in Neurodegeneration
Neurodegenerative disorders are currently incurable devastating diseases which are characterized by the slow and progressive loss of neurons in specific brain regions. Progress in the investigation of the mechanisms of these disorders helped to identify a number of genes associated with familial forms of these diseases and a number of toxins and risk factors which trigger sporadic and toxic forms of these diseases. Recently, some similarities in the mechanisms of neurodegenerative diseases were identified, including the involvement of mitochondria, oxidative stress, and the abnormality of Ca2+ signaling in neurons and astrocytes. Thus, mitochondria produce reactive oxygen species during metabolism which play a further role in redox signaling, but this may also act as an additional trigger for abnormal mitochondrial calcium handling, resulting in mitochondrial calcium overload. Combinations of these factors can be the trigger of neuronal cell death in some pathologies. Here, we review the latest literature on the crosstalk of reactive oxygen species and Ca2+ in brain mitochondria in physiology and beyond, considering how changes in mitochondrial metabolism or redox signaling can convert this interaction into a pathological event.
Top-30
Journals
|
1
2
3
4
5
6
7
8
|
|
|
Antioxidants
8 publications, 6.45%
|
|
|
International Journal of Molecular Sciences
7 publications, 5.65%
|
|
|
Cells
5 publications, 4.03%
|
|
|
Frontiers in Pharmacology
2 publications, 1.61%
|
|
|
Free Radical Biology and Medicine
2 publications, 1.61%
|
|
|
Schizophrenia Bulletin
2 publications, 1.61%
|
|
|
NeuroToxicology
2 publications, 1.61%
|
|
|
Ageing Research Reviews
2 publications, 1.61%
|
|
|
Biomolecules
2 publications, 1.61%
|
|
|
Neural Regeneration Research
2 publications, 1.61%
|
|
|
Frontiers in Immunology
2 publications, 1.61%
|
|
|
Scientific Reports
2 publications, 1.61%
|
|
|
Journal of Translational Medicine
2 publications, 1.61%
|
|
|
Frontiers in Molecular Biosciences
1 publication, 0.81%
|
|
|
Frontiers in Pain Research
1 publication, 0.81%
|
|
|
Frontiers in Neurology
1 publication, 0.81%
|
|
|
Frontiers in Cardiovascular Medicine
1 publication, 0.81%
|
|
|
Pharmaceuticals
1 publication, 0.81%
|
|
|
Plant Foods for Human Nutrition
1 publication, 0.81%
|
|
|
Neurochemical Research
1 publication, 0.81%
|
|
|
Mechanisms of Ageing and Development
1 publication, 0.81%
|
|
|
Foods
1 publication, 0.81%
|
|
|
Neurochemistry International
1 publication, 0.81%
|
|
|
Neuroscience and Biobehavioral Reviews
1 publication, 0.81%
|
|
|
Tissue and Cell
1 publication, 0.81%
|
|
|
Cell Death Discovery
1 publication, 0.81%
|
|
|
GLIA
1 publication, 0.81%
|
|
|
ACS Chemical Neuroscience
1 publication, 0.81%
|
|
|
Cellular and Molecular Neurobiology
1 publication, 0.81%
|
|
|
1
2
3
4
5
6
7
8
|
Publishers
|
5
10
15
20
25
30
35
|
|
|
Elsevier
33 publications, 26.61%
|
|
|
Springer Nature
29 publications, 23.39%
|
|
|
MDPI
26 publications, 20.97%
|
|
|
Frontiers Media S.A.
10 publications, 8.06%
|
|
|
Wiley
6 publications, 4.84%
|
|
|
Oxford University Press
3 publications, 2.42%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 publications, 2.42%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 1.61%
|
|
|
American Chemical Society (ACS)
1 publication, 0.81%
|
|
|
SciELO
1 publication, 0.81%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.81%
|
|
|
Research Square Platform LLC
1 publication, 0.81%
|
|
|
Portland Press
1 publication, 0.81%
|
|
|
Medknow
1 publication, 0.81%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.81%
|
|
|
IGI Global
1 publication, 0.81%
|
|
|
SAGE
1 publication, 0.81%
|
|
|
Taylor & Francis
1 publication, 0.81%
|
|
|
5
10
15
20
25
30
35
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.